The DOI matches its Crossref record; 92 of the 92 references it cites were found in a registry or an index.
Multiple system atrophy: A primary oligodendrogliopathy
Abstract
To this day, the cause of multiple system atrophy (MSA) remains stubbornly enigmatic. A growing body of observations regarding the clinical, morphological, and biochemical phenotypes of MSA has been published, but the interested student is still left without a clue as to its underlying cause. MSA has long been considered a rare cousin of Parkinson's disease and cerebellar degeneration; it is rich in acronyms but poor in genetic and environmental leads. Because of the worldwide research efforts conducted over the last two decades and the discovery of the α‐synuclein–encoding SNCA gene as a cause of rare familial Parkinson's disease, the MSA field has seen advances on three fronts: the identification of its principal cellular target, that is, oligodendrocytes; the characterization of α‐synuclein–rich glial cytoplasmic inclusions as a suitable marker at autopsy; and improved diagnostic accuracy in living patients resulting from detailed clinicopathological studies. The working model of MSA as a primary glial disorder was recently strengthened by the finding of dysregulation in the metabolism of myelin basic protein and p25α, a central nervous system–specific phosphoprotein (also called tubulin polymerization promoting protein, TPPP). Intriguingly, in early cases of MSA, the oligodendrocytic changes in myelin basic protein and p25α processing were recorded even before formation of glial cytoplasmic inclusions became detectable. Here, we review the evolving concept that MSA may not just be related to Parkinson's disease but also share traits with the family of demyelinating disorders. Although these syndromes vary in their respective cause of oligodendrogliopathy, they have in common myelin disruption that is often followed by axonal dysfunction. Ann Neurol 2008;64:239–246
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Immunology of multiple sclerosis
Sospedra, M., & Martin, R. (2005) · Annual Review of Immunology · doi:10.1146/annurev.immunol.23.021704.115707 · Cited by 2,149
Biology of Oligodendrocyte and Myelin in the Mammalian Central Nervous System
Baumann, N., & Pham-Dinh, D. (2001) · Physiological Reviews · doi:10.1152/physrev.2001.81.2.871 · Cited by 1,828
Consensus statement on the diagnosis of multiple system atrophy
Gilman, S., Low, P., Quinn, N., Albanese, A., Ben-Shlomo, Y., Fowler, C., Kaufmann, H., Klockgether, T., Lang, A., Lantos, P., et al. (1998) · Clinical Autonomic Research · doi:10.1007/bf02309628 · Cited by 1,308
Self-citationEnvironmental risk factors for multiple sclerosis. Part I: The role of infection
Ascherio, A., & Munger, K. L. (2007) · Annals of Neurology · doi:10.1002/ana.21117 · Cited by 1,042
Grazia Spillantini, M., Anthony Crowther, R., Jakes, R., Cairns, N. J., Lantos, P. L., & Goedert, M. (1998) · Neuroscience Letters · doi:10.1016/s0304-3940(98)00504-7 · Cited by 1,025
Papp, M. I., Kahn, J. E., & Lantos, P. L. (1989) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(89)90219-0 · Cited by 991 · cited 1×
“Accumulating evidence suggests to us that the “nature of the beast”(2) in MSA can now be slightly better defined, namely, as a unique entity within the spectrum of gliadegenerative illnesses.(18,19) Today, we consider MSA to represent a primary oligodendrogliopathy that features early myelin dysfunction, progressive s…”
BackgroundMultiple sclerosis: a complicated picture of autoimmunity
McFarland, H. F., & Martin, R. (2007) · Nature Immunology · doi:10.1038/ni1507 · Cited by 985
Consensus statement on the diagnosis of multiple system atrophy
Gilman, S., Low, P. A., Quinn, N., Albanese, A., Ben-Shlomo, Y., Fowler, C. J., Kaufmann, H., Klockgether, T., Lang, A. E., Lantos, P. L., et al. (1999) · Journal of the Neurological Sciences · doi:10.1016/s0022-510x(98)00304-9 · Cited by 917
Self-citationClinical features and natural history of multiple system atrophy: An analysis of 100 cases
Wenning, G. K., Shlomo, Y. B., Magalhães, M., Danie, S. E., & Quinn, N. P. (1994) · Brain · doi:10.1093/brain/117.4.835 · Cited by 788
Self-citationAxon-Glial Signaling and the Glial Support of Axon Function
Nave, K.-A., & Trapp, B. D. (2008) · Annual Review of Neuroscience · doi:10.1146/annurev.neuro.30.051606.094309 · Cited by 658
Ouimet, C., Miller, P., Hemmings, H., Walaas, S., & Greengard, P. (1984) · The Journal of Neuroscience · doi:10.1523/jneurosci.04-01-00111.1984 · Cited by 656
Multiple system atrophy--the nature of the beast.
Quinn, N. (1989) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.52.suppl.78 · Cited by 644
Heterogeneity of multiple sclerosis pathogenesis: implications for diagnosis and therapy
Lassmann, H., Brück, W., & Lucchinetti, C. (2001) · Trends in Molecular Medicine · doi:10.1016/s1471-4914(00)01909-2 · Cited by 627
Frontotemporal dementia: Clinicopathological correlations
Forman, M. S., Farmer, J., Johnson, J. K., Clark, C. M., Arnold, S. E., Coslett, H. B., Chatterjee, A., Hurtig, H. I., Karlawish, J. H., Rosen, H. J., et al. (2006) · Annals of Neurology · doi:10.1002/ana.20873 · Cited by 478
Wenning, G. K., Colosimo, C., Geser, F., & Poewe, W. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(03)00662-8 · Cited by 469
Self-citationBraak, H., Sastre, M., & Del Tredici, K. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0244-3 · Cited by 462
Tokuda, T., Salem, S. A., Allsop, D., Mizuno, T., Nakagawa, M., Qureshi, M. M., Locascio, J. J., Schlossmacher, M. G., & El-Agnaf, O. M. A. (2006) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2006.08.024 · Cited by 425
Self-citationBower, J. H., Maraganore, D. M., McDonnell, S. K., & Rocca, W. A. (1997) · Neurology · doi:10.1212/wnl.49.5.1284 · Cited by 399
Mollenhauer, B., Cullen, V., Kahn, I., Krastins, B., Outeiro, T. F., Pepivani, I., Ng, J., Schulz-Schaeffer, W., Kretzschmar, H. A., McLean, P. J., et al. (2008) · Experimental Neurology · doi:10.1016/j.expneurol.2008.06.004 · Cited by 382 · cited 2×
“The assumption that oligodendroglial function, SNCA metabolism, and GCI formation are pathogenetically intertwined is indirectly supported by the finding of early, but transient expression of endogenous snca SNCA messenger RNA and ASyn protein in oligodendroglial cell cultures from normal rat brain.(89) However, scien…”
BackgroundSelf-citationProposed neuropathological criteria for the post mortem diagnosis of multiple system atrophy
Trojanowski, J. Q., Revesz, T., & the Neuropathology Working Group on MSA (2007) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2007.00907.x · Cited by 349
Wakabayashi, K., Hayashi, S., Kakita, A., Yamada, M., Toyoshima, Y., Yoshimoto, M., & Takahashi, H. (1998) · Acta Neuropathologica · doi:10.1007/s004010050918 · Cited by 347
Neuropathological spectrum of synucleinopathies
Jellinger, K. A. (2003) · Movement Disorders · doi:10.1002/mds.10557 · Cited by 340
Self-citationParkin Localizes to the Lewy Bodies of Parkinson Disease and Dementia with Lewy Bodies
Schlossmacher, M. G., Frosch, M. P., Gai, W. P., Medina, M., Sharma, N., Forno, L., Ochiishi, T., Shimura, H., Sharon, R., Hattori, N., et al. (2002) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)61113-3 · Cited by 325
Self-citationHyperphosphorylation and insolubility of α‐synuclein in transgenic mouse oligodendrocytes
Kahle, P. J., Neumann, M., Ozmen, L., Müller, V., Jacobsen, H., Spooren, W., Fuss, B., Mallon, B., Macklin, W. B., Fujiwara, H., et al. (2002) · The EMBO Reports · doi:10.1093/embo-reports/kvf109 · Cited by 314
Yazawa, I., Giasson, B. I., Sasaki, R., Zhang, B., Joyce, S., Uryu, K., Trojanowski, J. Q., & Lee, V. M.-Y. (2005) · Neuron · doi:10.1016/j.neuron.2005.01.032 · Cited by 301
Clinical usefulness of magnetic resonance imaging in multiple system atrophy
Schrag, A., Kingsley, D., Phatouros, C., Mathias, C. J., Lees, A. J., Daniel, S. E., & Quinn, N. P. (1998) · Journal of Neurology, Neurosurgery & Psychiatry · doi:10.1136/jnnp.65.1.65 · Cited by 275
GATA transcription factors directly regulate the Parkinson's disease-linked gene α-synuclein
Scherzer, C. R., Grass, J. A., Liao, Z., Pepivani, I., Zheng, B., Eklund, A. C., Ney, P. A., Ng, J., McGoldrick, M., Mollenhauer, B., et al. (2008) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0802437105 · Cited by 270
Self-citationShults, C. W., Rockenstein, E., Crews, L., Adame, A., Mante, M., Larrea, G., Hashimoto, M., Song, D., Iwatsubo, T., Tsuboi, K., et al. (2005) · The Journal of Neuroscience · doi:10.1523/jneurosci.3527-05.2005 · Cited by 254
[ 11 C]( R )-PK11195 PET imaging of microglial activation in multiple system atrophy
Gerhard, A., Banati, R. B., Goerres, G. B., Cagnin, A., Myers, R., Gunn, R. N., Turkheimer, F., Good, C. D., Mathias, C. J., Quinn, N., et al. (2003) · Neurology · doi:10.1212/01.wnl.0000078192.95645.e6 · Cited by 246
Campbell, B. C. V., McLean, C. A., Culvenor, J. G., Gai, W. P., Blumbergs, P. C., Jäkälä, P., Beyreuther, K., Masters, C. L., & Li, Q. (2001) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.2001.00021.x · Cited by 225
Paviour, D. C., Price, S. L., Jahanshahi, M., Lees, A. J., & Fox, N. C. (2006) · Brain · doi:10.1093/brain/awl021 · Cited by 218
Stefanova, N., Reindl, M., Neumann, M., Kahle, P. J., Poewe, W., & Wenning, G. K. (2007) · Movement Disorders · doi:10.1002/mds.21671 · Cited by 217
Self-citationParkinson disease, 10 years after its genetic revolution: Multiple clues to a complex disorder
Klein, C., & Schlossmacher, M. G. (2007) · Neurology · doi:10.1212/01.wnl.0000271880.27321.a7 · Cited by 211
Self-citationStefanova, N., Reindl, M., Neumann, M., Haass, C., Poewe, W., Kahle, P. J., & Wenning, G. K. (2005) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)62307-3 · Cited by 208
Self-citationp25α Relocalizes in Oligodendroglia from Myelin to Cytoplasmic Inclusions in Multiple System Atrophy
Song, Y. J. C., Lundvig, D. M. S., Huang, Y., Gai, W. P., Blumbergs, P. C., Højrup, P., Otzen, D., Halliday, G. M., & Jensen, P. H. (2007) · The American Journal of Pathology · doi:10.2353/ajpath.2007.070201 · Cited by 204
Grading of neuropathology in multiple system atrophy: Proposal for a novel scale
Jellinger, K. A., Seppi, K., & Wenning, G. K. (2005) · Movement Disorders · doi:10.1002/mds.20537 · Cited by 202
Self-citationThe Definition of Multiple System Atrophy: A Review of Recent Developments
LANTOS, P. L. (1998) · Journal of Neuropathology and Experimental Neurology · doi:10.1097/00005072-199812000-00001 · Cited by 199
Absence of α-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia
Miller, D. W., Johnson, J. M., Solano, S. M., Hollingsworth, Z. R., Standaert, D. G., & Young, A. B. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0378-1 · Cited by 198
Lindersson, E., Lundvig, D., Petersen, C., Madsen, P., Nyengaard, J. R., Højrup, P., Moos, T., Otzen, D., Gai, W.-P., Blumbergs, P. C., et al. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m410409200 · Cited by 196
Oligodendrocyte lineage and the motor neuron connection
Richardson, W. D., Smith, H. K., Sun, T., Pringle, N. P., Hall, A., & Woodruff, R. (2000) · Glia · doi:10.1002/(sici)1098-1136(20000115)29:2<136::aid-glia6>3.0.co;2-g · Cited by 191
Cellular pathology in multiple system atrophy
Wakabayashi, K., & Takahashi, H. (2006) · Neuropathology · doi:10.1111/j.1440-1789.2006.00713.x · Cited by 158
Duda, J. E., Giasson, B. I., Gur, T., Montine, T. J., Robertson, D., Biaggioni, I., Hurtig, H. I., Stern, M. B., Gollomp, S. M., Grossman, M., et al. (2000) · Journal of Neuropathology & Experimental Neurology · doi:10.1093/jnen/59.9.830 · Cited by 152
Multiplex Families With Multiple System Atrophy
Hara, K., Momose, Y., Tokiguchi, S., Shimohata, M., Terajima, K., Onodera, O., Kakita, A., Yamada, M., Takahashi, H., Hirasawa, M., et al. (2007) · Archives of Neurology · doi:10.1001/archneur.64.4.545 · Cited by 149
Croisier, E., & Graeber, M. B. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0119-z · Cited by 139
Gai, W. P., Power, J. H., Blumbergs, P. C., Culvenor, J. G., & Jensen, P. H. (1999) · PubMed · Cited by 136
Survival in multiple system atrophy
Schrag, A. E., Wenning, G. K., Quinn, N. P., & Ben‐Shlomo, Y. (2007) · Movement Disorders · doi:10.1002/mds.21839 · Cited by 130
Self-citationMyelin Degeneration in Multiple System Atrophy Detected by Unique Antibodies
Matsuo, A., Akiguchi, I., Lee, G. C., McGeer, E. G., McGeer, P. L., & Kimura, J. (1998) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)65617-9 · Cited by 130
Multiple system atrophy: cellular and molecular pathology
Burn, D. J., & Jaros, E. (2001) · Molecular Pathology · doi:10.1136/mp.54.6.419 · Cited by 130
Nishie, M., Mori, F., Yoshimoto, M., Takahashi, H., & Wakabayashi, K. (2004) · Neuropathology and Applied Neurobiology · doi:10.1111/j.1365-2990.2004.00564.x · Cited by 123
The role of ?-synuclein in the pathogenesis of multiple system atrophy
Wenning, G. K., & Jellinger, K. A. (2005) · Acta Neuropathologica · doi:10.1007/s00401-004-0935-y · Cited by 123
Self-citationGai, W. P., Power, J. H. T., Blumbergs, P. C., Culvenor, J. G., & Jensen, P. H. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.02093.x · Cited by 122
Arima, K., Murayama, S., Mukoyama, M., & Inose, T. (1992) · Acta Neuropathologica · doi:10.1007/bf00310020 · Cited by 121
Cell Death Mechanisms in Multiple System Atrophy
Probst‐Cousin, S., Rickert, C. H., Schmid, K. W., & Gullota, F. (1998) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199809000-00002 · Cited by 110
Animal models of multiple system atrophy
Stefanova, N., & Wenning, G. K. (2015) · Clinical Autonomic Research · doi:10.1007/s10286-014-0266-6 · Cited by 98
Self-citationGai, W. P., Pountney, D. L., Power, J. H. T., Li, Q. X., Culvenor, J. G., McLean, C., Jensen, P. H., & Blumbergs, P. C. (2003) · Experimental Neurology · doi:10.1016/s0014-4886(03)00004-9 · Cited by 97
Murayama, S., Arima, K., Nakazato, Y., Satoh, J., Oda, M., & Inose, T. (1992) · Acta Neuropathologica · doi:10.1007/bf00427212 · Cited by 93
Nosology of Parkinson’s Disease: Looking for the Way Out of a Quackmire
Forman, M. S., Lee, V. M. ‐., & Trojanowski, J. Q. (2005) · Neuron · doi:10.1016/j.neuron.2005.07.021 · Cited by 90
Seppi, K., Schocke, M. F. H., Donnemiller, E., Esterhammer, R., Kremser, C., Scherfler, C., Diem, A., Jaschke, W. R., Wenning, G. K., & Poewe, W. H. (2004) · Movement Disorders · doi:10.1002/mds.20229 · Cited by 90
Self-citationMechanisms of cell death in neurodegenerative disorders
Jellinger, K. A., & Stadelmann, C. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6781-6_13 · Cited by 88
Self-citationOzawa, T. (2007) · Acta Neuropathologica · doi:10.1007/s00401-007-0254-1 · Cited by 85
Takahashi, M., Tomizawa, K., Ishiguro, K., Sato, K., Omori, A., Sato, S., Shiratsuchi, A., Uchida, T., & Imahori, K. (1991) · FEBS Letters · doi:10.1016/0014-5793(91)80903-g · Cited by 82
Takahashi, M., Tomizawa, K., Fujita, S. C., Sato, K., Uchida, T., & Imahori, K. (1993) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.1993.tb05842.x · Cited by 80
Kato, S., Nakamura, H., Hirano, A., Itô, H., Llena, J. F., & Yen, S. H. (1991) · Acta Neuropathologica · doi:10.1007/bf00293383 · Cited by 79
Sone, M., Yoshida, M., Hashizume, Y., Hishikawa, N., & Sobue, G. (2005) · Acta Neuropathologica · doi:10.1007/s00401-005-1013-9 · Cited by 77
Ishizawa, K., Komori, T., Arai, N., Mizutani, T., & Hirose, T. (2008) · Neuropathology · doi:10.1111/j.1440-1789.2007.00855.x · Cited by 77
Protein Aggregation Mechanisms in Synucleinopathies: Commonalities and Differences
Beyer, K., & Ariza, A. (2007) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/nen.0b013e3181587d64 · Cited by 76
A novel grading scale for striatonigral degeneration (multiple system atrophy)
Wenning, G. K., Seppi, K., Tison, F., & Jellinger, K. A. (2002) · Journal of Neural Transmission · doi:10.1007/s007020200025 · Cited by 76
Self-citationHeredity in multiple system atrophy
Soma, H., Yabe, I., Takei, A., Fujiki, N., Yanagihara, T., & Sasaki, H. (2005) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2005.09.003 · Cited by 71
Animal models of multiple system atrophy
Stefanova, N., Tison, F., Reindl, M., Poewe, W. H., & Wenning, G. K. (2005) · Trends in Neurosciences · doi:10.1016/j.tins.2005.07.002 · Cited by 71
Self-citationGlial cytoplasmic inclusions in neurologically normal elderly: prodromal multiple system atrophy?
Fujishiro, H., Ahn, T., Frigerio, R., DelleDonne, A., Josephs, K. A., Parisi, J. E., Ahlskog, J. E., & Dickson, D. W. (2008) · Acta Neuropathologica · doi:10.1007/s00401-008-0398-7 · Cited by 70
Langerveld, A. J., Mihalko, D., DeLong, C., Walburn, J., & Ide, C. F. (2007) · Movement Disorders · doi:10.1002/mds.21259 · Cited by 69
The brain-specific protein TPPP/p25 in pathological protein deposits of neurodegenerative diseases
Kovács, G. G., Gelpí, E., Lehotzky, A., Höftberger, R., Erdei, A., Budka, H., & Ovádi, J. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0167-4 · Cited by 68
TPPP/p25: from unfolded protein to misfolding disease: prediction and experiments
Orosz, F., Kovács, G. G., Lehotzky, A., Oláh, J., Vincze, O., & Ovádi, J. (2004) · Biology of the Cell · doi:10.1016/j.biolcel.2004.08.002 · Cited by 67
Abé, H., Yagishita, S., Amano, N., Iwabuchi, K., Hasegawa, K., & Kowa, K. (1992) · Acta Neuropathologica · doi:10.1007/bf00227820 · Cited by 66
Cyclin-Dependent Kinase 5 Is a Regulator of Podocyte Differentiation, Proliferation, and Morphology
Griffin, S., Hiromura, K., Pippin, J. W., Petermann, A. T., Blonski, M. J., Krofft, R. D., Takahashi, S., Kulkarni, A. B., & Shankland, S. J. (2004) · American Journal Of Pathology · doi:10.1016/s0002-9440(10)63378-0 · Cited by 65
Phosphorylation Blocks the Activity of Tubulin Polymerization-promoting Protein (TPPP)
Hlavanda, E., Klement, É., Kókai, E., Kovács, J., Vincze, O., Tőkési, N., Orosz, F., Medzihradszky, K. F., Dombrádi, V., & Ovádi, J. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m703466200 · Cited by 64
Putaminal lesion in multiple system atrophy: postmortem MR-pathological correlations
Matsusue, E., Fujii, S., Kanasaki, Y., Sugihara, S., Miyata, H., Ohama, E., & Ogawa, T. (2008) · Neuroradiology · doi:10.1007/s00234-008-0381-y · Cited by 62
Accumulation of 14‐3‐3 proteins in glial cytoplasmic inclusions in multiple system atrophy
Kawamoto, Y., Akiguchi, I., Nakamura, S., & Budka, H. (2002) · Annals of Neurology · doi:10.1002/ana.10361 · Cited by 54
How to diagnose MSA early: the role of magnetic resonance imaging
Seppi, K., Schocke, M. F. H., Wenning, G. K., & Poewe, W. H. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0332-2 · Cited by 53
Self-citationChanges in the activity of cdk2 and cdk5 accompany differentiation of rat primary oligodendrocytes
Tang, X., Strocchi, P., & Cambi, F. (1998) · Journal of Cellular Biochemistry · Cited by 51
The role of α-synuclein and tau in neurodegenerative movement disorders
Wenning, G. K., & Jellinger, K. A. (2005) · Current Opinion in Neurology · doi:10.1097/01.wco.0000168241.53853.32 · Cited by 46
Self-citationExperimental models of spontaneous autoimmune disease in the central nervous system
Krishnamoorthy, G., Holz, A., & Wekerle, H. (2007) · Journal of molecular medicine · doi:10.1007/s00109-007-0218-x · Cited by 46
Kawamoto, Y., Akiguchi, I., Shirakashi, Y., Honjo, Y., Tomimoto, H., Takahashi, R., & Budka, H. (2006) · Brain Research · doi:10.1016/j.brainres.2006.12.049 · Cited by 40
Multiple system atrophy in a patient with the spinocerebellar ataxia 3 gene mutation
Nirenberg, M. J., Libien, J. M., Vonsattel, J., & Fahn, S. (2006) · Movement Disorders · doi:10.1002/mds.21231 · Cited by 38
van Geel, W. J. A., Abdo, W. F., Melis, R. J. F., Williams, S., Bloem, B. R., & Verbeek, M. M. (2007) · Journal of Neuroscience Methods · doi:10.1016/j.jneumeth.2007.09.021 · Cited by 37
Tau and 14-3-3 in glial cytoplasmic inclusions of multiple system atrophy
Giasson, B. I., Mabon, M. E., Duda, J. E., Montine, T. J., Robertson, D., Hurtig, H. I., Lee, V. M. ‐., & Trojanowski, J. Q. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0726-x · Cited by 36
Kurnellas, M., Donahue, K., & Elkabes, S. (2007) · Biochemical Society Transactions · doi:10.1042/bst0350923 · Cited by 35
Ozawa, T. (2006) · Acta Neuropathologica · doi:10.1007/s00401-006-0109-1 · Cited by 34
Arai, N., Nishimura, M., Oda, M., Morimatsu, Y., Ohe, R., & Nagatomo, H. (1992) · Journal of the Neurological Sciences · doi:10.1016/0022-510x(92)90101-p · Cited by 31
Immunoexpression of 14-3-3 proteins in glial cytoplasmic inclusions of multiple system atrophy
Komori, T., Ishizawa, K., Arai, N., Hirose, T., Mizutani, T., & Oda, M. (2003) · Acta Neuropathologica · doi:10.1007/s00401-003-0702-5 · Cited by 21
(2000) · doi:10.1002/1097-4547(20001001)62:1<9::aid-jnr2>3.0.co;2-u
Cited by
Fanciulli, A., & Wenning, G. K. (2015) · New England Journal of Medicine · doi:10.1056/nejmra1311488 · Cited by 809
Self-citationMollenhauer, B., Locascio, J. J., Schulz-Schaeffer, W., Sixel-Döring, F., Trenkwalder, C., & Schlossmacher, M. G. (2011) · The Lancet Neurology · doi:10.1016/s1474-4422(11)70014-x · Cited by 622
Self-citationBasic mechanisms of neurodegeneration: a critical update
Jellinger, K. A. (2010) · Journal of Cellular and Molecular Medicine · doi:10.1111/j.1582-4934.2010.01010.x · Cited by 596
Self-citationParkinson’s disease induced pluripotent stem cells with triplication of the α-synuclein locus
Devine, M. J., Ryten, M., Vodicka, P., Thomson, A. J., Burdon, T., Houlden, H., Cavaleri, F., Nagano, M., Drummond, N. J., Taanman, J.-W., et al. (2011) · Nature Communications · doi:10.1038/ncomms1453 · Cited by 486
Will the real multiple sclerosis please stand up?
Stys, P. K., Zamponi, G. W., van Minnen, J., & Geurts, J. J. G. (2012) · Nature Reviews Neuroscience · doi:10.1038/nrn3275 · Cited by 475
Metadata
- Authors
- Wenning, G. K., Stefanova, N., Jellinger, K. A., Poewe, W., & Schlossmacher, M. G.
- Venue
- Annals of Neurology
- Publisher
- Wiley
- Published
- 2008-09-28
- Volume
- 64
- Issue
- 3
- Pages
- 239-246
- ISSN
- 0364-5134 (ISSN-L)
- 1531-8249
- OpenAlex
- W2103976813
- Cited by
- 324
- References
- 92
- FWCI
- 13.75
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.